Patent ID: 11969536
Assignee: FENWAL, INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 17:
18. The blood separation device of claim 10, wherein the controller is programmed to
determine a preference for execution of the first version of the therapeutic plasma exchange procedure upon determining or receiving input indicating that: (1) there is a limited time to complete the therapeutic plasma procedure or that a shorter procedure time is preferred, (2) blood to be separated is provided by a blood source having hypercholesteremia, (3) there is a preference for a reduced risk of damaging a cellular blood component or that blood to be separated is provided by a blood source having a condition causing weakening of a cellular blood component, (4) platelets are not to be returned to the blood source, and/or (5) blood to be separated is provided by a blood source that is an adult, and
determine a preference for execution of the second version of the therapeutic plasma exchange procedure upon determining or receiving input indicating that: (1) the therapeutic plasma exchange procedure will require eight or more hours to complete, (2) platelets are to be returned to the blood source, (3) blood to be separated is provided by a blood source that is a child, (4) a relatively low cost of a fluid flow circuit used in combination with the blood separation device during execution of the therapeutic plasma exchange procedure is preferred, and/or (5) a shape, shape, and/or density of red blood cells in blood to be separated is abnormal.